NanoViricides
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NanoViricides and other ETFs, options, and stocks.About NNVC
NanoViricides, Inc. is a clinical stage company, which engages in the development of nano-biopharmaceutical drugs against viruses. It focuses on anti-viral therapeutics through internal discovery and clinical development programs.
CEOAnil R. Diwan
CEOAnil R. Diwan
Employees7
Employees7
HeadquartersShelton, Connecticut
HeadquartersShelton, Connecticut
Founded2005
Founded2005
Employees7
Employees7
NNVC Key Statistics
Market cap24.77M
Market cap24.77M
Price-Earnings ratio-2.81
Price-Earnings ratio-2.81
Dividend yield—
Dividend yield—
Average volume362.16K
Average volume362.16K
High today$1.49
High today$1.49
Low today$1.36
Low today$1.36
Open price$1.47
Open price$1.47
Volume327.33K
Volume327.33K
52 Week high$2.23
52 Week high$2.23
52 Week low$0.94
52 Week low$0.94
Stock Snapshot
The current NanoViricides(NNVC) stock price is $1.38, with a market capitalization of 24.77M. The stock trades at a price-to-earnings (P/E) ratio of -2.81.
As of 2025-12-09, NanoViricides(NNVC) stock has fluctuated between $1.36 and $1.49. The current price stands at $1.38, placing the stock +1.2% above today's low and -7.6% off the high.
NanoViricides(NNVC) shares are trading with a volume of 327.33K, against a daily average of 362.16K.
In the last year, NanoViricides(NNVC) shares hit a 52-week high of $2.23 and a 52-week low of $0.94.
In the last year, NanoViricides(NNVC) shares hit a 52-week high of $2.23 and a 52-week low of $0.94.
People also own
Based on the portfolios of people who own NNVC. This list is generated using Robinhood data, and it’s not a recommendation.